exv25w3

Troy Kilpatrick, President

Frank P. Sulzberger, MD

Directors (Trustees)

William D. Lindelof, VP

Exhibit 25.3

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM T-1

STATEMENT OF ELIGIBILITY
UNDER THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE

CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY
OF A TRUSTEE PURSUANT TO SECTION 305(b)(2)

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.

(Exact name of trustee as specified in its charter)


Delaware		95-3571558
(State of incorporation if not a U.S. national bank)		(I.R.S. employer identification no.)

700 South Flower Street, Suite 500
Los Angeles, California		90017
(Address of principal executive offices)		(Zip code)

INVERNESS MEDICAL INNOVATIONS, INC.
(Exact name of obligor as specified in its charter)
(See table of additional obligors on following page)


Delaware (State of incorporation if not a U.S. national bank)		04-3565120 (I.R.S. employer identification no.)

51 Sawyer Road, Suite 200		02453
Waltham, Massachusetts		(Zip code)
(Address of principal executive offices)

Senior Notes Due 2016

(Title of the indenture securities)

TABLE OF ADDITIONAL OBLIGORS

Some or all of the following direct and indirect wholly owned domestic subsidiaries of Inverness Medical Innovations, Inc. are expected to guarantee the debt securities issued pursuant to the Indenture. The address, including zip code, and telephone number, including area code, of each of the co-obligors is 51 Sawyer Road, Suite 200, Waltham, Massachusetts, 02453, (781) 647-3900:


	State or other
	jurisdiction of
Exact name of additional registrant	incorporation or	I.R.S. Employer
as specified in its charter	organization	Identification Number
Advantage Diagnostics Corporation	Delaware		20-1247157
Alere LLC	Delaware		26-2564744
Alere CDM LLC	Delaware		27-0653943
Alere Healthcare of Illinois, Inc.	Georgia		58-2068880
Alere Health Improvement Company	Delaware		23-2776413
Alere Health Systems, Inc.	Delaware		22-3493126
Alere Medical, Inc.	California		94-3238845
Alere Wellology, Inc.	Delaware		54-1776557
Alere Women’s and Children’s Health, LLC	Delaware		58-2205984
Ameditech Inc.	California		33-0859551
Applied Biotech, Inc.	California		33-0447325
Binax, Inc.	Delaware		20-2507302
Biosite Incorporated	Delaware		33-0288606
Cholestech Corporation	Delaware		94-3065493
First Check Diagnostics Corp.	Delaware		20-8329751
First Check Ecom, Inc.	Massachusetts		33-1026518
Genecare Medical Genetics Center, Inc.	North Carolina		56-1348485
Hemosense, Inc.	Delaware		77-0452938
IM US Holdings, LLC	Delaware		26-0349667
Innovacon, Inc.	Delaware		20-1100264
Innovations Research, LLC	Delaware		20-0653511
Innovative Mobility, LLC	Florida		20-0351538
Instant Technologies, Inc.	Virginia		54-1837621
Inverness Medical, LLC	Delaware		26-0392649
Inverness Medical — Biostar Inc.	Delaware		91-1929582
Inverness Medical Innovations North America,	Delaware		26-1444559
Inc. Inverness Medical International Holding Corp.	Delaware		80-0077873
Inverness Medical International Holding Corp. II	Delaware		20-0963463
Ischemia Technologies, Inc.	Delaware		84-1489537
IVC Industries, Inc.	Delaware		22-1567481
Matria of New York, Inc.	New York		58-1873062
Matritech, Inc.	Delaware		26-1436477
Ostex International, Inc.	Washington		91-1450247
Quality Assured Services, Inc.	Florida		59-3437644
Redwood Toxicology Laboratory, Inc.	California		68-0332937
RTL Holdings, Inc.	Delaware		20-4371685
Selfcare Technology, Inc.	Delaware		04-3383533
Wampole Laboratories, LLC	Delaware		37-1485678

- 2 -

General information. Furnish the following information as to the trustee:

(a)

Name and address of each examining or supervising authority to which it is subject.


Name		Address
Comptroller of the Currency – United States Department of the Treasury		Washington, D.C. 20219

Federal Reserve Bank		San Francisco, California 94105

Federal Deposit Insurance Corporation		Washington, D.C. 20429

	(b)		Whether it is authorized to exercise corporate trust powers.

			Yes.

2.		Affiliations with Obligor.

		If the obligor is an affiliate of the trustee, describe each such affiliation.

		None.

16.		List of Exhibits.

		Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the “Act”) and 17 C.F.R. 229.10(d).

	1.		A copy of the articles of association of The Bank of New York Mellon Trust Company, N.A. (Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121948 which is incorporated by reference).

	2.		A copy of certificate of authority of the trustee to commence business. (Exhibit 2 to Form T-1 filed with Registration Statement No. 333-121948 which is incorporated by reference).

	3.		A copy of the authorization of the trustee to exercise corporate trust powers. (Exhibit 3 to Form T-1 filed with Registration Statement No. 333-121948 which is incorporated by reference).

	4.		A copy of the existing by-laws of the trustee. (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-121948 which is incorporated by reference).

	5.		Not applicable.

	6.		The consent of the trustee required by Section 321(b) of the Act. (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-121948 which is incorporated by reference).

- 3 -

	7.		A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority.

	8.		Not applicable.

	9.		Not applicable.

- 4 -

SIGNATURE

Pursuant to the requirements of the Act, the trustee, The Bank of New York Mellon Trust Company, N.A., a banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in The City of Boston, and State of Massachusetts, on the 4^th day of August, 2009.


THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
By:	/s/ Peter M. Murphy
	Name:	Peter M. Murphy
	Title:	Vice President

- 5 -

EXHIBIT 7

Consolidated Report of Condition of
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
of 700 South Flower Street, Suite 200, Los Angeles, CA 90017

At the close of business December 31, 2008, published in accordance with Federal regulatory authority instructions.


	Dollar Amounts
	in Thousands
ASSETS

Cash and balances due from depository institutions:
Noninterest-bearing balances and currency and coin		2,739
Interest-bearing balances		0
Securities:
Held-to-maturity securities		26
Available-for-sale securities		430,112
Federal funds sold and securities purchased under agreements to resell:
Federal funds sold		28,500
Securities purchased under agreements to resell		50,000
Loans and lease financing receivables:
Loans and leases held for sale		0
Loans and leases, net of unearned income		0
LESS: Allowance for loan and lease losses		0
Loans and leases, net of unearned income and allowance		0
Trading assets		0
Premises and fixed assets (including capitalized leases)		11,261
Other real estate owned		0
Investments in unconsolidated subsidiaries and associated companies		1
Not applicable
Intangible assets:
Goodwill		876,153
Other intangible assets		272,502
Other assets		181,657

Total assets	$	1,852,951

- 6 -


	Dollar Amounts
	in Thousands
LIABILITIES

Deposits:
In domestic offices		1,765
Noninterest-bearing		1,765
Interest-bearing		0
Not applicable
Federal funds purchased and securities sold under agreements to repurchase:
Federal funds purchased		0
Securities sold under agreements to repurchase		0
Trading liabilities		0
Other borrowed money:
(includes mortgage indebtedness and obligations under capitalized leases)		268,691
Not applicable
Not applicable
Subordinated notes and debentures		0
Other liabilities		166,958
Total liabilities		437,414
Minority interest in consolidated subsidiaries		0

EQUITY CAPITAL

Perpetual preferred stock and related surplus		0
Common stock		1,000
Surplus (exclude all surplus related to preferred stock)		1,121,520
Retained earnings		290,517
Accumulated other comprehensive income		2,500
Other equity capital components		0

Total equity capital		1,415,537

Total liabilities, minority interest, and equity capital		1,852,951

I, Karen Bayz, Vice President of the above-named bank do hereby declare that the Reports of Condition and Income (including the supporting schedules) for this report date have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true to the best of my knowledge and belief.

Karen Bayz ) Vice President

We, the undersigned directors (trustees), attest to the correctness of the Report of Condition (including the supporting schedules) for this report date and declare that it has been examined by us and to the best of our knowledge and belief has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true and correct.

- 7 -